Biomedical Translation Fund (BTF)
The Australian Government has established a $501.25 million Biomedical Translation Fund (BTF) with $250 million of Commonwealth capital and $251.25 million private sector capital.
The BTF is an equity co-investment venture capital program announced in the National Innovation and Science Agenda that: supports commercialisation of biomedical discoveries in Australia; and helps translate biomedical discoveries into high growth potential companies to deliver long term health benefits and national economic outcomes.
Funding is available through three private sector venture capital fund managers which are investing in companies with promising biomedical innovations with commercial potential.
AusIndustry is delivering the BTF on behalf of the Australian Government Department of Health.
The Australian Government is inviting organisations through an open, non-competitive process to apply for grant funding under the Veteran and Community Grants Program from 1 July 2019 to 30 June 2020. The objective of the program is to maintain and improve the...read more
The Australian Government is inviting applications through an open competitive process to apply to deliver services under the Multicultural Affairs and Citizenship Program: Fostering Integration Grants in 2019-20. The objective of the grant opportunity is to...read more
The $50 million Manufacturing Modernisation Fund supports manufacturers to modernise, adopt new technologies, become more productive and create more jobs by co-funding capital investments and associated reskilling. Modernisation can include technology upgrades,...read more
The objectives of the grant opportunity are to: Deliver nationally accredited training to primary health care professionals who provide services to Aboriginal and Torres Strait Islander people, to develop their skills, knowledge and competency to provide ear and...read more